CBT
Undervalued by 18.6% based on the discounted cash flow analysis.
Market cap | $4.21 Billion |
---|---|
Enterprise Value | $5.33 Billion |
Dividend Yield | $1.74 (2.2202373357152%) |
Earnings per Share | $6.79 |
Beta | 0.85 |
Outstanding Shares | 54,000,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 9.77 |
---|---|
PEG | 82.1 |
Price to Sales | 1.09 |
Price to Book Ratio | 2.7 |
Enterprise Value to Revenue | 1.36 |
Enterprise Value to EBIT | 8.17 |
Enterprise Value to Net Income | 12 |
Total Debt to Enterprise | 0.25 |
Debt to Equity | 0.93 |
No data
No data